Kosoglou T - Search Results

1

The plasma concentration and LDL-C relationship in patients receiving ezetimibe.

Ezzet F, Wexler D, Statkevich P, Kosoglou T, Patrick J, Lipka L, Mellars L, Veltri E, Batra V. Ezzet F, et al. Among authors: kosoglou t. J Clin Pharmacol. 2001 Sep;41(9):943-9. doi: 10.1177/00912700122010915. J Clin Pharmacol. 2001. PMID: 11549098 Clinical Trial.

2

Pharmacodynamic interaction between the new selective cholesterol absorption inhibitor ezetimibe and simvastatin.

Kosoglou T, Meyer I, Veltri EP, Statkevich P, Yang B, Zhu Y, Mellars L, Maxwell SE, Patrick JE, Cutler DL, Batra VK, Affrime MB. Kosoglou T, et al. Br J Clin Pharmacol. 2002 Sep;54(3):309-19. doi: 10.1046/j.1365-2125.2002.01633.x. Br J Clin Pharmacol. 2002. PMID: 12236852 Free PMC article. Clinical Trial.

3

Effects of ezetimibe on the pharmacodynamics and pharmacokinetics of lovastatin.

Kosoglou T, Statkevich P, Meyer I, Cutler DL, Musiol B, Yang B, Zhu Y, Maxwell SE, Veltri EP. Kosoglou T, et al. Curr Med Res Opin. 2004 Jun;20(6):955-65. doi: 10.1185/030079904125003872. Curr Med Res Opin. 2004. PMID: 15200755 Clinical Trial.

4

A population pharmacokinetic model that describes multiple peaks due to enterohepatic recirculation of ezetimibe.

Ezzet F, Krishna G, Wexler DB, Statkevich P, Kosoglou T, Batra VK. Ezzet F, et al. Among authors: kosoglou t. Clin Ther. 2001 Jun;23(6):871-85. doi: 10.1016/s0149-2918(01)80075-8. Clin Ther. 2001. PMID: 11440287 Clinical Trial.

5

Assessment of a multiple-dose drug interaction between ezetimibe, a novel selective cholesterol absorption inhibitor and gemfibrozil.

Reyderman L, Kosoglou T, Statkevich P, Pember L, Boutros T, Maxwell SE, Affrime M, Batra V. Reyderman L, et al. Among authors: kosoglou t. Int J Clin Pharmacol Ther. 2004 Sep;42(9):512-8. doi: 10.5414/cpp42512. Int J Clin Pharmacol Ther. 2004. PMID: 15487810 Clinical Trial.

6

Disposition of the selective cholesterol absorption inhibitor ezetimibe in healthy male subjects.

Patrick JE, Kosoglou T, Stauber KL, Alton KB, Maxwell SE, Zhu Y, Statkevich P, Iannucci R, Chowdhury S, Affrime M, Cayen MN. Patrick JE, et al. Among authors: kosoglou t. Drug Metab Dispos. 2002 Apr;30(4):430-7. doi: 10.1124/dmd.30.4.430. Drug Metab Dispos. 2002. PMID: 11901097 Clinical Trial.

7

Pharmacodynamic interaction between ezetimibe and rosuvastatin.

Kosoglou T, Statkevich P, Yang B, Suresh R, Zhu Y, Boutros T, Maxwell SE, Tiessen R, Cutler DL. Kosoglou T, et al. Curr Med Res Opin. 2004 Aug;20(8):1185-95. doi: 10.1185/030079904125004213. Curr Med Res Opin. 2004. PMID: 15324521 Clinical Trial.

8

Pharmacodynamic and pharmacokinetic interaction between fenofibrate and ezetimibe.

Kosoglou T, Statkevich P, Fruchart JC, Pember LJ, Reyderman L, Cutler DL, Guillaume M, Maxwell SE, Veltri EP. Kosoglou T, et al. Curr Med Res Opin. 2004 Aug;20(8):1197-207. doi: 10.1185/030079903125004277. Curr Med Res Opin. 2004. PMID: 15324522 Clinical Trial.

9

Pharmacokinetic interaction between ezetimibe and lovastatin in healthy volunteers.

Reyderman L, Kosoglou T, Boutros T, Seiberling M, Statkevich P. Reyderman L, et al. Among authors: kosoglou t. Curr Med Res Opin. 2004 Sep;20(9):1493-500. doi: 10.1185/030079904X2547. Curr Med Res Opin. 2004. PMID: 15383199 Clinical Trial.

10

Ezetimibe: a review of its metabolism, pharmacokinetics and drug interactions.

Kosoglou T, Statkevich P, Johnson-Levonas AO, Paolini JF, Bergman AJ, Alton KB. Kosoglou T, et al. Clin Pharmacokinet. 2005;44(5):467-94. doi: 10.2165/00003088-200544050-00002. Clin Pharmacokinet. 2005. PMID: 15871634 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Search Page

Filters